A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Acute sinusitis is also typically accompanied by systemic signs such as fever, leukocytosis, and lassitude, along with purulent nasal discharge. The patient may report an olfactory disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results